Entellus Medical (ENTL) Tops Q2 EPS by 5c, Offers Q3 & FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. SPY
10. FISV

Go back to Entellus Medical (ENTL) Tops Q2 EPS by 5c, Offers Q3 & FY Guidance

Entellus Medical Announces Second Quarter 2015 Financial Results

August 6, 2015 4:02 PM EDT

PLYMOUTH, Minn., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. ("Entellus Medical" or the "Company") (NASDAQ: ENTL), a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, today reported its financial results for the quarter ended June 30, 2015.

Recent Highlights and Accomplishments

Revenues of $15.2 million in the second quarter of 2015, an increase of 22% versus the second quarter of 2014 Commercially launched the XprESS LoProfile Multi-Sinus Dilation System in Europe... More